Skip to main content
Log in

Management of idiopathic thrombocytopenic purpura

  • Controversies in Pediatrics
  • Published:
The Indian Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Idiopathic thrombocytopenic purpura is not an uncommon bleeding disorder with a prevalence of 40–80 per million children per year. Over the last six decades, the subject of ITP has attracted the attention of pediatricians and hematologists. It is one of the subjects which has many controversies because of its unpredictable course heralded by remission relapses, and chronicity with mortality in less than 1% of cases. In the present review only the controversies in the management of acute and chronic ITP have been reviewed as it interests most pediatricians. Management of intracranial hemorrhage (ICH), severe gastrointestinal hemorrhage and menorrhagia continues to still remain a challenge in spite of newer therapies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Beardsley DS. Platelet abnormalities in infancy and childhood. In: Nathan DG, and Oski FA, eds.Hematology of infancy and childhood 4 ed. WB Saunders Company Philadidlpua 1993; 1561–1604.

    Google Scholar 

  2. Dubansky AS and Oski FA. Controversies in the management of acute idiopathic thrombocytopenic purpura. A survey of specialists.Pediatrics 1986; 77: 49–52.

    PubMed  CAS  Google Scholar 

  3. Buchanan GR. Childhood ITP: How many tests and how much treatment required.J Pediatr 1985; 106: 928–930.

    Article  PubMed  CAS  Google Scholar 

  4. Buchanan GR, and Holtkamp CA. Prednisone therapy for children with newly diagnosed idiopathic thrombocytopenic purpura. A randomized clinical trial.Am J Pediatr Hematol Oncol 1984; 6: 355–361.

    Article  PubMed  CAS  Google Scholar 

  5. Sartorius JA. Steroid treatment of idiopathic thrombocytopenic purpura in childhood. Preliminary results of a randomized cooperative study.Am J Pediatr Hematol Oncol 1984; 6: 165–169.

    PubMed  CAS  Google Scholar 

  6. von dem Borne AE and Vod JJ,et al. High dose intravenous methylprednisolone or high dose intravenous gammaglobulin for autoimmune thrombocytopenia.Br Med J (Clin Res) 1988; 269: 249.

    Google Scholar 

  7. Imbach P, D’Apuzzo V, Hirt Aet al. High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood.Lancet 1981; 1: 1228–1230.

    Article  PubMed  CAS  Google Scholar 

  8. Imbach P, Berchtold W, Hirt A,et al. Intravenous IgG versus oral corticosteroids in acute immune thrombocytopenic purpura of childhood.Lancet 1985; 11: 464–468.

    Article  Google Scholar 

  9. Blanchette VS, Luke B, Andrew M,et al. A prospective, randomized trial of high-dose intravenous immune globulin G therapy, oral prednisone therapy, and no therapy in childhood acute immune thrombocytopenic purpura.J Pediatr 1993; 123: 989–995.

    Article  PubMed  CAS  Google Scholar 

  10. Albayrak D, Islek I, Kelayee AG,et al. Acute immune thrombocytopenic purpura. A comparative study of very high oral doses of methylprednisolone and intravenously administered immune globulin. J Pediatr 1994; 125: 1004–1007.

    Article  PubMed  CAS  Google Scholar 

  11. Blanchette VS, Imbach P, Andrew Met al. Randomized trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisolone in childhood acute immune thrombocytopenic purpura. Lancet 1994; 344: 703–707.

    Article  PubMed  CAS  Google Scholar 

  12. Krishnamurti L, Charan VD, Desai N, Pati H and Choudhry VP. Anti D immunoglobulin in the treatment of idiopathic thrombocytopenic purpura.Ind J Pediatr 1994; 61: 179.

    CAS  Google Scholar 

  13. Medeiros D and Buchanan R. Current controversies in the management of idiopathic thrombocytopenic purpura.Ped Clin N Amer 1996; 43: 757–772.

    Article  CAS  Google Scholar 

  14. Bussel JB, Graziano JN, Kimberly RPet al. Intravenous anti-D treatment of immune thrombocytopenic purpura. Analysis of efficacy, toxicity, and mechanism of effect.Blood 1991; 77: 1884–1893.

    PubMed  CAS  Google Scholar 

  15. Schreiber AD, Chien P, Tomaski A, Cines DB. Effect of danazol in immune thrombocytopenic purpura.N Engl J Med 1987; 316: 503–508.

    Article  PubMed  CAS  Google Scholar 

  16. Choudhry VP, Kashyap R, Ahlawat S, Pati HP. Vinblastine and danazol therapy in steroid resistant childhood chronic idiopathic purpura.Int J Hematol 1995; 61: 157–162.

    Article  PubMed  CAS  Google Scholar 

  17. Proctor SJ, Jackson G, Carey Pet al. Improvement of platelet count in steroid unresponsive idiopathic immune thrombocytopenic purpura after short course therapy with recombinant alpha-2b interferon.Blood 1989; 74: 1894–1897.

    PubMed  CAS  Google Scholar 

  18. Godeau B, Oksenbendler E, Ier Ling P. Dapsone for autoimmune thrombocytopenic purpura.Am J Hematol 1993; 49: 70–72.

    Article  Google Scholar 

  19. Belak M, Widder RA, Brunner Ret al. Immunoadsorption with protein a Sepharose of silica.Lancet 1994; 343: 792–793.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Choudhry, V.P., Kashyap, R. & Pati, H.P. Management of idiopathic thrombocytopenic purpura. Indian J Pediatr 65, 401–407 (1998). https://doi.org/10.1007/BF02761134

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02761134

Key words

Navigation